Nature Reviews Drug Discovery3d agoIncretin-based multi-agonist reverses obesity and diabetesSarah CrunkhornNature Reviews Drug Discovery, Published online: 22 May 2026; doi:10.1038/d41573-026-00087-5 Incretin-based multi-agonist reverses obesity and diabetesRead at Nature Reviews Drug DiscoveryTagsdiabetesmedicineobesitypharmacology
